"Cancer"

Pancreatic cancer is a complex disease that affects the patient's body, often with pain and loss of weight, so it needs to be treated promptly.

The Royal Marsden Hospital was founded in 1851 and was the first hospital in the world dedicated to cancer. The Royal Marsden Cancer Centre is the largest comprehensive cancer centre in Europe and is regarded as one of the top three cancer centres in the world, treating over 60,000 NHS and self-funded patients each year.

The US FDA approved a new treatment for non-small cell lung cancer - Tremelimumab + Durvalumab + platinum-based chemotherapy. The triple combination therapy significantly improves efficacy and patient survival and has a good safety profile.

MD Anderson Cancer Center, founded in 1941, is a world-renowned oncology hospital located in Houston, Texas, USA, and was one of the three early comprehensive cancer treatment centres designated by the National Cancer Initiative in 1971. It is one of the first three comprehensive cancer treatment centres designated by the National Cancer Initiative in 1971, and one of 39 comprehensive cancer treatment centres designated by the Medical Oncology Society, and is recognised as a good cancer hospital.

The Dana-Farber Cancer Institute, founded in 1947, is a specialist cancer hospital affiliated with Harvard Medical School, a federally designated comprehensive cancer treatment centre in the United States, and has produced one Nobel Laureate in medicine.

Prostate cancer, which has been increasing in incidence worldwide in recent years, is now a more common cancer among Japanese men. Often, patients with prostate cancer have a poor prognosis and poor survival once they have developed multiple recurrent metastases after treatment with hormones and are difficult to treat with conventional radiotherapy.

Cervical cancer is one of the most common gynecological malignancies. Its incidence rate is second only to endometrial cancer worldwide, and it ranks first in developing countries and regions. According to statistics, there are 450000 new cases of cervical cancer worldwide every year. The occurrence and development of cervical cancer usually go through a relatively long process, so it is possible to prevent this disease.

Every year, 40000 women die of breast cancer in the United States alone. When cancers are discovered at an early stage, they can often be cured. Mammography is the best alternative diagnostic method, but this method also has shortcomings. It often results in false positive results, leading to unnecessary surgery.

Recently, the European Commission has approved cemiplimab-rwlc (Libtayo), manufactured by US-based Regeneron, as a monotherapy for the treatment of adult patients with recurrent or metastatic cervical cancer whose disease has progressed during or after platinum-containing chemotherapy. The results of the trial showed that this therapy significantly improved patient survival and had a good safety profile.

The FDA granted Fast Track designation to a new drug, IK-175, in combination with nabumab for the treatment of advanced uroepithelial carcinoma, after preliminary trial data showed encouraging and durable anti-tumor activity with a favorable safety profile.